ctrl K

Halozyme Therapeutics Inc... (HALO)

NASDAQ: HALO · Real-Time Price · USD

60.11

-1.31 (-2.13%)

At close: May 01, 2025, 3:59 PM

60.91

1.33%

Pre-market: May 02, 2025, 07:06 AM EDT

Halozyme Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
PE Ratio	13.65	17.32	38.52	14.04	45.07	-35.42	-26.12	43.89	-12.2
PEG Ratio	0.21	0.39	-0.8	0.07	-0.16	3.31	0.12	-0.28	-0.05
PS Ratio	5.97	5.88	11.80	12.76	21.74	13.06	13.82	8.73	8.57
PB Ratio	16.67	58.18	45.86	28.71	38.51	27.89	8.43	13.26	-38.69
P/FCF Ratio	12.95	13.06	33.09	18.98	109.87	-28.6	-38.75	20.83	-23.48
P/OCF Ratio	12.66	12.55	32.43	18.89	104.90	-29.96	-42.4	20.62	-24.94
OCF/S Ratio	0.47	0.47	0.36	0.68	0.21	-0.44	-0.33	0.42	-0.34
Debt / Equity Ratio	4.14	17.89	8.87	4.45	2.63	4.39	0.51	0.97	-6.67
Quick Ratio	6.78	5.50	4.88	7.45	1.17	6.00	2.71	3.85	4.43
Current Ratio	7.80	6.64	5.65	7.91	1.32	6.35	2.86	3.89	4.70
Asset Turnover	0.49	0.48	0.36	0.40	0.46	0.35	0.34	0.61	0.56
Interest Coverage	30.48	17.99	15.79	36.66	7.08	-5.81	-3.84	3.68	-4.17
Return on Equity	1.22	3.36	1.19	2.04	0.85	-0.79	-0.32	0.30	3.17
Return on Assets	0.22	0.16	0.11	0.36	0.22	-0.13	-0.18	0.12	-0.39
Return on Invested Capital	0.23	0.17	0.13	0.42	0.27	-0.15	-0.18	0.18	-0.38
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	0.84	0.77	0.79	0.82	0.84	0.77	0.93	0.90	0.77
Net Profit Margin	0.44	0.34	0.31	0.91	0.48	-0.37	-0.53	0.20	-0.7
Pretax Profit Margin	0.55	0.42	0.38	0.56	0.48	-0.37	-0.53	0.19	-0.69
Operating Profit Margin	0.54	0.41	0.41	0.62	0.54	-0.34	-0.46	0.26	-0.57
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	0.65	0.55	0.48	0.58	0.57	-0.29	-0.46	0.26	-0.54